BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX)

Historical Holders from Q2 2019 to Q2 2025

Symbol
BLRX on Nasdaq
Type / Class
Equity / Ordinary shares, par value NIS 0.10 per share
Shares outstanding
2,048,819,940
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
6
Holdings value
$1
% of all portfolios
0%
Number of holders
1
Number of buys
1
Average buys %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 4.99% $11,245,973 102,236,115 Mitchell P. Kopin 06 Jan 2025

Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q2 6 $1 +$1 $0.1667 1
2025 Q1 0 $0 -$419,312 0
2024 Q4 2,035,990 $431,583 -$638,844 $0.2140 31
2024 Q3 2,485,707 $1,330,214 -$508,007 $0.5361 30
2024 Q2 4,254,744 $2,420,823 +$1,636,472 $0.5699 30
2024 Q1 1,281,349 $1,434,885 +$235,347 $1.12 26
2023 Q4 1,114,666 $1,750,366 -$436,655 $1.57 27
2023 Q3 1,353,450 $2,463,071 +$250,703 $1.82 29
2023 Q2 1,237,434 $1,972,853 -$1,642,894 $1.60 25
2023 Q1 3,285,670 $2,912,789 -$1,659,100 $0.8865 19
2022 Q4 5,709,266 $3,367,239 -$4,319,903 $0.5900 15
2022 Q3 11,165,600 $10,326,500 +$9,299,239 $0.9246 26
2022 Q2 1,058,935 $1,355,706 -$179,987 $1.28 25
2022 Q1 1,160,391 $1,981,000 -$2,555,536 $1.71 24
2021 Q4 2,493,881 $5,085,134 -$58,440 $2.04 28
2021 Q3 2,432,734 $6,684,438 +$2,764,684 $2.75 29
2021 Q2 1,424,343 $4,011,037 -$9,544,830 $2.81 27
2021 Q1 4,821,050 $13,451,381 +$8,353,671 $2.79 28
2020 Q4 1,826,935 $4,603,033 -$3,147,375 $2.52 19
2020 Q3 4,038,640 $6,625,021 +$1,453,711 $1.64 15
2020 Q2 3,169,067 $5,419,022 +$729,223 $1.71 13
2020 Q1 2,750,333 $3,665,017 +$45,959 $1.33 9
2019 Q4 2,713,411 $6,106,029 +$432,144 $2.25 9
2019 Q3 2,513,372 $6,633,034 +$6,628,034 $2.64 11
2019 Q2 12,712 $5,000 +$5,000 $0.3933 1